Euclidean Capital LLC — 13F Holdings & Portfolio
CIK 1825034 · latest 13F-HR filed 2026-08-14
Euclidean Capital LLC manages $439.8M in 13F-reported U.S. long-equity assets across 11 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are VEU (61.76%), VTV (25.76%), INDA (4.15%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 1 new position, exited 0, added to 5, and trimmed 3.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
149 FIFTH AVE, 14TH FL
NEW YORK, NY 10010
$439.8M
Long-equity book
11
Distinct positions
2026-06-30
Filed 2026-08-14
+1 / −0 / ↑5 / ↓3
vs 2026-03-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- VANGUARD INTL EQUITY INDEX F$28.1M +11.5%
- VANGUARD INDEX FDS$11.3M +11.1%
- ISHARES TR$942.5K +5.4%
- PMV PHARMACEUTICALS INC$262.8K +8.1%
- TENAYA THERAPEUTICS INC$47.4K +6.7%
Top Trims
- ORIC PHARMACEUTICALS INC-$1.8M -14.5%
- SURROZEN INC-$278.9K -10.9%
- ALECTOR INC-$183.1K -6.5%
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | VANGUARD INTL EQUITY INDEX F | VEU | 922042775 | $271.6M | 61.76% | 3,243,484 | SH |
| 2 | VANGUARD INDEX FDS | VTV | 922908744 | $113.3M | 25.76% | 520,000 | SH |
| 3 | ISHARES TR | INDA | 46429B598 | $18.3M | 4.15% | 369,600 | SH |
| 4 | ORIC PHARMACEUTICALS INC | ORIC | 68622P109 | $10.7M | 2.44% | 989,410 | SH |
| 5 | TEAMSHARES INC | TMS | 87821B109 | $9.0M | 2.06% | 1,099,974 | SH |
| 6 | FOGHORN THERAPEUTICS INC | FHTX | 344174107 | $7.7M | 1.75% | 1,573,761 | SH |
| 7 | PMV PHARMACEUTICALS INC | PMVP | 69353Y103 | $3.5M | 0.80% | 2,627,643 | SH |
| 8 | ALECTOR INC | ALEC | 014442107 | $2.6M | 0.60% | 1,307,858 | SH |
| 9 | SURROZEN INC | SRZN | 86889P208 | $2.3M | 0.52% | 87,696 | SH |
| 10 | TENAYA THERAPEUTICS INC | TNYA | 87990A106 | $750.7K | 0.17% | 1,015,705 | SH |
| 11 | SURROZEN INC | SRZN | 86889P117 | $2.8K | 0.00% | 170,833 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-14 | $439.8M | 11 | 0001012975-26-000776 |
| 2026-03-31 | 2026-05-15 | $392.3M | 10 | 0001012975-26-000442 |
| 2025-12-31 | 2026-02-17 | $369.5M | 12 | 0001012975-26-000154 |
| 2025-09-30 | 2025-11-14 | $238.0M | 11 | 0001012975-25-000761 |